Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Filters
Karl Peace
Professor, Georgia Cancer Coalition Distinguished Cancer Scholar, Jiann-Ping College of Public HealthGeorgia Southern University
Karl Peace researches biostatistics, clinical trials and drug research and development.
Joshua Grill
Director of the Institute for Memory Impairments and Nerological Disorders at UCIUC Irvine
Joshua Grill directs a major Alzheimer's disease research institute helps lead the national strategy for AD clinical trial recruitment.
Nicole Onetto
Deputy Director and Chief Scientific OfficerOntario Institute for Cancer Research
Dr. Onetto is responsible for developing and maintaining relationships with cancer research stakeholders.
Nicholas J. Petrelli, M.D.
Bank of America Endowed Medical Director, Helen F. Graham Cancer Center and Research InstituteChristianaCare
Nicholas J. Petrelli is a nationally recognized expert on cancer.
John Ligon
Assistant ProfessorUniversity of Florida
Dr. John Ligon is a translational researcher committed to advancing novel cellular therapies and immunotherapies.
Jorge Cortes, MD
Director, Georgia Cancer CenterAugusta University
Jorge Cortes is a clinical investigator who has helped research and develop multiple treatment options for chronic myeloid leukemia.
Guogen Shan
ProfessorUniversity of Florida
Guogen Shan is an expert in longitudinal data analysis, cognitive neuroscience, and clinical trial design and analysis.
Thomas George
M.D. | Professor | Interim DirectorUniversity of Florida
Dr. Thomas George is a medical oncologist and clinical investigator focusing on gastrointestinal malignancies and new cancer treatments.
Jack Whelan
Research Advocate - Event SpeakerJack-Whelan.com
Inspire audience: see Clinical Trials as safe & effective treatment option vs conventional chemo as we travel road to Personalized Medicine
Chris Martens
Associate Professor, Kinesiology & Applied PhysiologyUniversity of Delaware
Prof. Martens's laboratory is interested in understanding mechanisms by which impaired vascular function contributes to cognitive declines.